YAP1 is required for the angiogenesis in retinal microvascular endothelial cells via the inhibition of MALAT1‐mediated miR‐200b‐3p in high glucose‐induced diabetic retinopathy
Authors:
- 16 July 2019
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 235 (2) , 1309-1320
Abstract
Diabetic retinopathy (DR) is one of the severest complications in the development of diabetes with a characteristic of intraretinal new vessel formation. Our present study attempts to probe into the involvement of Yes‐associated protein 1 (YAP1) in retinal microvascular endothelial cells (RMECs) and the underlying mechanism. The DR mouse model was induced by streptozotocin injection and a high‐glucose/high‐fat diet. After that, with the utilization of the Pearson's correlation analysis, the correlation between YAP1 and metastasis‐associated lung adenocarcinoma transcript 1 (MALAT1) was analyzed. The relationship between microRNA‐200b‐3p (miR‐200b‐3p) and MALAT1 or vascular endothelial growth factor A (VEGFA) was then validated. Finally, the cellular processes including the abilities of proliferation, migration, as well as tube formation, were evaluated after the alteration of YAP1, MALAT1, and miR‐200b‐3p expression. YAP1 was observed to be highly expressed in retinas from DR mice, which promoted the cellular processes of RMECs through upregulating the MALAT1 expression. It was further confirmed that MALAT1 could sponge miR‐200b‐3p, and miR‐200b‐3p directly targeted VEGFA. When YAP1 was silenced, the RMEC proliferation, migration, and angiogenesis in the retina of DR mice were reduced. From these data, we conclude that YAP1 may exert some promotive effects on the development of DR through its regulation of the MALAT1/miR‐200b‐3p/VEGFA axis, highlighting that YAP1 silencing may be instrumental for the therapeutic targeting of DR.Keywords
This publication has 29 references indexed in Scilit:
- Altered Retinal MicroRNA Expression Profiles in Early Diabetic Retinopathy: AnIn SilicoAnalysisCurrent Eye Research, 2014
- microRNA in the development of diabetic complicationsClinical Science, 2013
- VEGFA and tumour angiogenesisJournal of Internal Medicine, 2013
- Diverse roles for VEGF-A in the nervous systemDevelopment, 2012
- The Role of Angiogenesis in the Development of Proliferative Diabetic Retinopathy: Impact of Intravitreal Anti-VEGF TreatmentExperimental Diabetes Research, 2012
- Regulation of Vascular Endothelial Growth Factor Signaling by miR-200bMolecules and Cells, 2011
- MicroRNA-200b Regulates Vascular Endothelial Growth Factor–Mediated Alterations in Diabetic RetinopathyDiabetes, 2011
- Diabetic Retinopathy: Targeting VasoregressionDiabetes, 2011
- Diabetic retinopathyThe Lancet, 2010
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001